EP0453561A4 - Chimeric mouse human antibodies with specificity to hiv antigens - Google Patents

Chimeric mouse human antibodies with specificity to hiv antigens

Info

Publication number
EP0453561A4
EP0453561A4 EP19910901136 EP91901136A EP0453561A4 EP 0453561 A4 EP0453561 A4 EP 0453561A4 EP 19910901136 EP19910901136 EP 19910901136 EP 91901136 A EP91901136 A EP 91901136A EP 0453561 A4 EP0453561 A4 EP 0453561A4
Authority
EP
European Patent Office
Prior art keywords
specificity
human antibodies
chimeric mouse
hiv antigens
mouse human
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP19910901136
Other languages
English (en)
Other versions
EP0453561A1 (fr
Inventor
Marc D. Better
Arnold H. Horwitz
Pradip Ghosh-Dastidar
Randy R. Robinson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Xoma Royalty Corp
Original Assignee
Xoma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xoma Corp filed Critical Xoma Corp
Publication of EP0453561A1 publication Critical patent/EP0453561A1/fr
Publication of EP0453561A4 publication Critical patent/EP0453561A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—RNA viruses
    • C07K16/112—Retroviridae (F), e.g. leukemia viruses
    • C07K16/114—Lentivirus (G), e.g. human immunodeficiency virus [HIV], feline immunodeficiency virus [FIV] or simian immunodeficiency virus [SIV]
    • C07K16/1145—Env proteins, e.g. gp41, gp110/120, gp160, V3, principal neutralising domain [PND] or CD4-binding site
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—RNA viruses
    • C07K16/112—Retroviridae (F), e.g. leukemia viruses
    • C07K16/114—Lentivirus (G), e.g. human immunodeficiency virus [HIV], feline immunodeficiency virus [FIV] or simian immunodeficiency virus [SIV]
    • C07K16/1143—Gag-pol proteins, e.g. p17or p24
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—RNA viruses
    • C07K16/112—Retroviridae (F), e.g. leukemia viruses
    • C07K16/114—Lentivirus (G), e.g. human immunodeficiency virus [HIV], feline immunodeficiency virus [FIV] or simian immunodeficiency virus [SIV]
    • C07K16/1147—Regulatory proteins, e.g. trans-activator of transcription [TAT], rev or vacuolar protein targeting [VPT]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against enzymes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/46—Hybrid immunoglobulins
    • C07K16/461—Igs containing Ig-regions, -domains or -residues form different species
    • C07K16/462—Igs containing a variable region (Fv) from one specie and a constant region (Fc) from another
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/036—Fusion polypeptide containing a localisation/targetting motif targeting to the medium outside of the cell, e.g. type III secretion

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Plant Pathology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Compositions Of Oxide Ceramics (AREA)
EP19910901136 1989-11-13 1990-11-13 Chimeric mouse human antibodies with specificity to hiv antigens Withdrawn EP0453561A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US43370389A 1989-11-13 1989-11-13
US433703 1989-11-13

Publications (2)

Publication Number Publication Date
EP0453561A1 EP0453561A1 (fr) 1991-10-30
EP0453561A4 true EP0453561A4 (en) 1993-02-10

Family

ID=23721227

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19910901136 Withdrawn EP0453561A4 (en) 1989-11-13 1990-11-13 Chimeric mouse human antibodies with specificity to hiv antigens

Country Status (6)

Country Link
EP (1) EP0453561A4 (fr)
JP (2) JPH04503609A (fr)
KR (2) KR920701441A (fr)
AU (2) AU6663990A (fr)
CA (2) CA2044627A1 (fr)
WO (1) WO1991007494A1 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0519866A1 (fr) * 1991-06-18 1992-12-23 Ciba-Geigy Ag Anticorps contre V.I.H.
US5665569A (en) * 1991-08-22 1997-09-09 Nissin Shokuhin Kabushiki Kaisha HIV immunotherapeutics
EP0581353A1 (fr) * 1992-07-03 1994-02-02 De Staat Der Nederlanden Vertegenwoordigd Door De Minister Van Welzijn, Volksgezondheid En Cultuur Anticorps monoclonaux dirigés contre HIV-1 gp120, lignées cellulaires les produisant et structures epitopiques correspondantes
WO1998001476A1 (fr) * 1996-07-10 1998-01-15 Nabi Neutralisation hautement synergique du vih par des combinaisons d'anticorps monoclonaux et polyclonaux
AU6518698A (en) * 1997-03-28 1998-10-22 Seikagaku Corporation Novel anti-hiv complexes and medicinal compositions
US20030035798A1 (en) 2000-08-16 2003-02-20 Fang Fang Humanized antibodies
EP1578917A4 (fr) 2001-07-19 2008-01-23 Perlan Therapeutics Inc Proteines multimeres et methodes de production et d'utilisation de ces proteines
WO2007068488A1 (fr) * 2005-12-15 2007-06-21 Micromet Ag Anticorps à domaines greffés
EP3077417A1 (fr) * 2013-12-08 2016-10-12 Peptcell Limited Antigènes et anticorps anti-vih, compositions, méthodes et utilisations
CN116143909B (zh) * 2021-11-20 2023-10-31 东莞市朋志生物科技有限公司 一种抗hiv-1 p24的抗体及其制备方法和用途

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0248534A2 (fr) * 1986-05-06 1987-12-09 Epitope, Inc. Méthode pour détecter une infection provoquée par le virus SIDA
EP0327000A2 (fr) * 1988-01-30 1989-08-09 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Fragments de gènes codant pour la région variable d'un anticorps anti-HIV, anticorps chimériques anti-HIV exprimés lors de leur utilisation et procédé pour leur préparation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3853779T2 (de) * 1987-05-29 1995-09-07 Baylor College Medicine Hiv-1 neutralisierende monoklonale antikörper.
WO1989005820A1 (fr) * 1987-12-21 1989-06-29 Arch Development Corporation Antigenes et anticorps associes au virus d'immunodeficience humaine

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0248534A2 (fr) * 1986-05-06 1987-12-09 Epitope, Inc. Méthode pour détecter une infection provoquée par le virus SIDA
EP0327000A2 (fr) * 1988-01-30 1989-08-09 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Fragments de gènes codant pour la région variable d'un anticorps anti-HIV, anticorps chimériques anti-HIV exprimés lors de leur utilisation et procédé pour leur préparation

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS vol. 160, no. 3, 15 May 1989, DULUTH, MINNESOTA US pages 1250 - 1256 LARRICK ET AL. 'Rapid cloning of rearranged immunoglobulin genes from human hybridoma cells' *
BIOCHIMICA ET BIOPHYSICA ACTA vol. 949, 1988, AMSTERDAM, NL pages 213 - 223 MARCUS-SEKURA ET AL. 'Reactivity of an HIV gag gene polypeptide expressed in E.coli with sera from AIDS patients and monoclonal antibodies to gag' *
BIOTECHNOLOGY vol. 7, no. 9, September 1989, NEW YORK US pages 934 - 938 LARRICK ET AL. 'Polymerase chain reaction using mixed primers: cloning of human monoclonal antibody variable region genes from single hybridoma cells' *
PROCEEDINGS OF THE 4TH INTERNATIONAL CONFERENCE ON AIDS June 1988, page 237 YOSHIHARA ET AL. 'HIV neutralization studies using anti-core and anti-envelope protein monoclonal antibodies' *
See also references of WO9107494A1 *

Also Published As

Publication number Publication date
WO1991007494A1 (fr) 1991-05-30
JPH03206888A (ja) 1991-09-10
EP0453561A1 (fr) 1991-10-30
AU6663990A (en) 1991-05-16
KR920701441A (ko) 1992-08-11
KR910009285A (ko) 1991-06-28
JPH04503609A (ja) 1992-07-02
AU6953091A (en) 1991-06-13
CA2044627A1 (fr) 1991-05-14
CA2044609A1 (fr) 1991-05-14

Similar Documents

Publication Publication Date Title
ZA8891B (en) Chimeric antibody with specificity to human b cell surface antigen
ZA884651B (en) Monoclonal antibody specific to hiv antigens
GR900100221A (en) Novel monoclonic antibodies against a new antigen relating to human tumours
EP0457875A4 (en) Chimeric mouse-human a10 antibody with specificity to a human tumor cell antigen
AU1085488A (en) Monoclonal antibodies to a pan-malarial antigen
GB2196634B (en) Monoclonal antibodies to hiv and related peptides
GB2186592B (en) Cross-protective human monoclonal antibody compositions
EP0453554A4 (en) Chimeric mouse human antibodies with specificity to hiv antigens
GB2218703B (en) Human monoclonal antibody to p.aeruginosa: its production and use
EP0453561A4 (en) Chimeric mouse human antibodies with specificity to hiv antigens
IL94624A0 (en) Human monoclonal antibodies to hiv-1 mn qq120
EP0311383A3 (en) Monoclonal antibody to methamphetamine, preparation of the same, assay method and assay kit of methamphetamine
AU1308288A (en) Method to stimulate the immune response to specific antigens
AU627591B2 (en) Chimeric mouse-human km10 antibody with specificity to a human tumor cell antigen
KR960001503B1 (en) Method for rdetecting antibodies to human immunodeficiency virus
EP0418347A4 (en) Human monoclonal antibodies to human immunodeficiency virus
IL83342A0 (en) Monoclonal antibodies,their preparation and their use
ZA883811B (en) Immunodiagnostic assays using chimeric antigens
AU2384688A (en) Monoclonal antibodies to a plasmodium falciparum protein
GB8714778D0 (en) Antibodies to interferon
GB8830115D0 (en) Monoclonal antibody and preparation and use thereof
IE880021L (en) Antibodies with specificity to human b cell surface antigen
CS792487A1 (en) Mouse lymphocytaric hybridome producing antibody against human alpha-fetoproteine
CS792687A1 (en) Mouse lymphocytaric hybridome producing antibody against human alpha-fetoproteine
AU1508088A (en) Monoclonal antibodies to specific antigenic regions of the human immunodeficiency virus and methods for use

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19910718

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IT LI LU NL SE

A4 Supplementary search report drawn up and despatched

Effective date: 19921221

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB GR IT LI LU NL SE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19940601